Viewing nowMavix Tablet 20mg (Memantine Hydrochloride)
Memantine Hydrochloride 20mg
Tablet · Prescription medication
Austin Pharmaceutical Co., Ltd.

MFDS item code 202401445 · Approved 2024.06.13 · Insurance code 654305590
Treatment of moderate to severe Alzheimer’s disease
This medication is used for the relief of symptoms and improvement of cognitive function in patients with moderate to severe Alzheimer’s disease.
This medicine should be administered orally once daily at the same time each day. If necessary, it may be administered twice daily. This medicine may be taken with or without food. 1. Adults Dose escalation: The maximum daily dose is 20mg. To minimize the risk of adverse reactions, increase the dose by 5mg per week over the first 3 weeks as follows to reach the maintenance dose. Week 1 (Days 1–7): Administer 5mg once daily for 7 days. Week 2 (Days 8–14): Administer 10mg once daily for 7 days. Week 3 (Days 15–21): Administer 15mg once daily for 7 days. From Week 4 onward, administer 20mg once daily. Maintenance dose: The recommended maintenance dose is 20mg once daily. 2. Older adults Based on clinical data, the recommended dose for older patients aged 65 years and older is 20mg once daily. 3. Patients with renal impairment No dose adjustment is required in patients with mild renal impairment (creatinine clearance: 50-80 mL/min). In patients with moderate renal impairment (creatinine clearance 30-49 mL/min), the daily dose should be reduced to 10mg. If well tolerated after at least 7 days of treatment, the dose may be increased to 20mg once daily according to the standard dose-escalation schedule. In patients with severe renal impairment (creatinine clearance 5-29 mL/min), the daily dose should be reduced to 10mg. 4. Patients with hepatic impairment No dose adjustment is required in patients with mild or moderate hepatic impairment (Child-Pugh A, Child-Pugh B). Since there are no data on the use of memantine in patients with severe hepatic impairment, it is preferable not to administer this medicine.
This medication should not be used in patients who are hypersensitive to its ingredients or have severe liver or kidney impairment. It should be administered with caution to patients with epilepsy, those who have experienced seizures in the past, or those at high risk of epilepsy. Moreover, the use of this medication in conjunction with NMDA antagonists such as amantadine, ketamine, or dextromethorphan may increase the risk of side effects, so concurrent use is not recommended. Patients with factors that may raise urine pH, such as drastic dietary changes, excessive intake of alkaline beverages, or specific urinary tract infections should be closely monitored. As the safety of this medication has not been established in patients with a recent history of myocardial infarction, congestive heart failure, or uncontrolled hypertension, caution is advised in such cases. Common side effects may include dizziness, headache, constipation, drowsiness, and hypertension, and if these symptoms become severe, one should consult a doctor. Central nervous system side effects such as mental confusion, hallucinations, and psychiatric reactions may also occur rarely, so monitoring is necessary. This medication can interact with other drugs, so when taken with NMDA antagonists, barbiturates, antipsychotic medications, skeletal muscle relaxants, anticoagulants, etc., it is essential to consult a doctor or pharmacist. Women who are pregnant or may become pregnant should consult a doctor before taking this medication, and nursing mothers are advised to discontinue breastfeeding. Use in children or adolescents under the age of 18 is not recommended as safety and efficacy have not been established. In case of overdose, symptoms such as confusion, drowsiness, dizziness, vomiting, and diarrhea may appear, necessitating immediate medical attention for appropriate treatment. This medication may affect the patient’s reaction time, so special caution is advised when driving or operating machinery. When storing, place in a secure location out of reach of children and avoid transferring to other containers.
Not everyone experiences these, and they can vary from person to person.
This medication is sensitive to air and moisture, so it should be stored in a sealed container. It is recommended to maintain a storage temperature between 1°C and 30°C.
Pink, oval-shaped film-coated tablet
30 tablets/box [10 tablets/PTP × 3], 30 tablets/bottle, 100 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowMemantine Hydrochloride 20mg
Tablet · Prescription medication
Austin Pharmaceutical Co., Ltd.
Memantine Hydrochloride 1g
Solution · Prescription medication
Lundbeck Korea Co., Ltd.

Memantine Hydrochloride 10mg
Tablet · Prescription medication
Lundbeck Korea Co., Ltd.

Memantine Hydrochloride 10mg
Tablet · Prescription medication
Ildong Pharmaceutical Co., Ltd.

Memantine Hydrochloride 10mg
Tablet · Prescription medication
Donghwa Pharmaceutical Co., Ltd.

Memantine Hydrochloride 10mg
Tablet · Prescription medication
Youngjin Pharmaceutical Co., Ltd.

Memantine Hydrochloride 10mg
Tablet · Prescription medication
Unimed Pharmaceutical Co., Ltd.

Memantine Hydrochloride 10mg
Tablet · Prescription medication
Myongin Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.